Louise F. Hill

City St George's
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Antiseptic Cleansing to Reduce Vertical Transmission of Pathogens to Neonates: The NeoVT-AMR Randomized Clinical Trial.

Antiseptic Cleansing to Reduce Vertical Transmission of Pathogens to Neonates: The NeoVT-AMR Randomized Clinical Trial.

Journal: JAMA network open

Published: June 11, 2026

Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1).

Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1).

Journal: Antimicrobial agents and chemotherapy

Published: December 29, 2025

A rapid time-resolved host gene expression signature predicts responses to antibiotic treatment in neonatal bacterial sepsis.

A rapid time-resolved host gene expression signature predicts responses to antibiotic treatment in neonatal bacterial sepsis.

Journal: Science translational medicine

Published: November 26, 2025

Neonatal sepsis definitions for randomised-controlled trials: challenges and approaches.

Neonatal sepsis definitions for randomised-controlled trials: challenges and approaches.

Journal: International journal of epidemiology

Published: October 20, 2025

Safety reporting in neonatal clinical trials: reflections towards optimal, globally relevant approaches.

Safety reporting in neonatal clinical trials: reflections towards optimal, globally relevant approaches.

Journal: Trials

Published: March 01, 2024

Need for standardized vancomycin dosing for coagulase-negative staphylococci in hospitalized infants.

Need for standardized vancomycin dosing for coagulase-negative staphylococci in hospitalized infants.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: June 09, 2022

Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.

Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.

Journal: The Lancet. Child & adolescent health

Published: April 29, 2021

An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial.

An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial.

Journal: Trials

Published: July 13, 2019

The £15 billion cost of ash dieback in Britain.

The £15 billion cost of ash dieback in Britain.

Journal: Current biology : CB

Published: May 08, 2019

Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model.

Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model.

Journal: Antimicrobial agents and chemotherapy

Published: January 10, 2019

Abundance distributions for tree species in Great Britain: A two-stage approach to modeling abundance using species distribution modeling and random forest.

Abundance distributions for tree species in Great Britain: A two-stage approach to modeling abundance using species distribution modeling and random forest.

Journal: Ecology and evolution

Published: October 16, 2016

Vancomycin toxicity in neonates: a review of the evidence.

Vancomycin toxicity in neonates: a review of the evidence.

Journal: Current opinion in infectious diseases

Published: February 20, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026